Glycostasis' Unattributed Round

Glycostasis raised a round of funding on June 11, 2015.

Glycostasis is a virtual drug development company focused on diabetes. The company's first drug will sense blood glucose and release an appropriate amount of insulin as needed, reducing the complicati…

Articles about Glycostasis' Unattributed Round: